http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101520545-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101520545-B1 |
| titleOfInvention | Composition for diagnosing muscle inflammation and uses thereof |
| abstract | The present invention provides information for the diagnosis of muscle inflammation comprising a composition for diagnosing muscle inflammation comprising an agent for measuring the level of miR-494, a kit for diagnosing muscle inflammation comprising said composition, and a step of measuring the level of miR-494 And screening a substance capable of lowering the level of miR-494. The present invention also relates to a method for screening a drug for preventing or treating muscle inflammation. MiR-494 provided in the present invention can be used as a diagnostic marker of muscle inflammation that causes insulin resistance accompanying the onset of muscle inflammation, and thus it can be widely used for effective diagnosis and treatment of muscle inflammation. |
| priorityDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 319.